康美药业陷入“财务造假”疑云事件舆情监测报告
2019年4月29日晚，中药饮片行业巨头康美药业发布2018年年度报告，同时宣布更正2017年年报中出现的“会计差错”。经过调整后，康美药业货币资金多计299.44亿元，营业收入多计89亿元，营业成本多计76.6亿元，合并现金流量表销售商品、提供劳务收到的现金项目多计103亿元，购买商品、接受劳务支付的现金项目多计73亿元，支付其他与经营活动有关的现金项目少计38.2亿元。业内人士认为康美药业存在财务造假，而康美药业创始人在公开致歉信中称，这是由“快速发展导致财务管理不完善”，并且在采访中回应“财务差错”与“财务造假”是两回事，然而这并不是康美药业第一次陷入“财务造假”疑云。
On April 29,2019,KANGMEI PHARMACEUTICAL CO., LTD,a giant in the Chinese herbal medicine industry,released its 2018 annual report and announced that it would correct the “accounting errors” that appeared in the 2017 annual report.After adjustment, KANGMEI PHARMACEUTICAL CO., LTD has a total of 29.94 billion yuan of monetary funds,operating income of 8.9 billion yuan, operating costs of 7.66 billion yuan,combined cash flow statement sales of goods,labor services received more cash items 10.3 billion yuan,more than 7.3 billion yuan in cash items for goods and services,and 3.82 billion yuan for other cash items related to business activities.The industry believes that KANGMEI PHARMACEUTICAL CO., LTD has financial fraud,and the founder of KANGMEI PHARMACEUTICAL CO., LTD stated in a public apology letter that this was caused by “rapid development resulting in imperfect financial management” and responded to “financial errors” in the interview. "It is different from "financial fraud",but this is not the first time KANGMEI PHARMACEUTICAL CO., LTD has fallen into the "financial fraud" cloud.
关于艾媒舆情
艾媒舆情（yq.iimedia.cn）是中国领先的大数据舆情咨询领导品牌，最新重磅推出舆情健康顾问产品——“艾媒舆情医生”。艾媒舆情医生基于先进的全网大数据监测和挖掘技术、可视化分析技术，为企业提供“舆情诊断、舆情咨询”的一站式服务，帮助企业及时预警、判断事态走向、应急处理突发舆情，维护企业良好的公共形象与用户口碑。
舆情诊断：独创企业分析监测模型，从热度、言值、舆论基调、传播矩阵、用户画像等多维度提供企业健康度体检报告
舆情咨询：7*24全天候监测不间断预警，帮助应对突发危机，灵活调整策略，提升市场竞争力，建立完善的竞争体系
